| Literature DB >> 36245570 |
Weiwei Zhang1, Shiyong Liu2, Nathaniel Osgood3,4, Hongli Zhu1, Ying Qian5, Peng Jia6,7.
Abstract
This study systematically reviews applications of three simulation approaches, that is, system dynamics model (SDM), agent-based model (ABM) and discrete event simulation (DES), and their hybrids in COVID-19 research and identifies theoretical and application innovations in public health. Among the 372 eligible papers, 72 focused on COVID-19 transmission dynamics, 204 evaluated both pharmaceutical and non-pharmaceutical interventions, 29 focused on the prediction of the pandemic and 67 investigated the impacts of COVID-19. ABM was used in 275 papers, followed by 54 SDM papers, 32 DES papers and 11 hybrid model papers. Evaluation and design of intervention scenarios are the most widely addressed area accounting for 55% of the four main categories, that is, the transmission of COVID-19, prediction of the pandemic, evaluation and design of intervention scenarios and societal impact assessment. The complexities in impact evaluation and intervention design demand hybrid simulation models that can simultaneously capture micro and macro aspects of the socio-economic systems involved.Entities:
Keywords: COVID‐19 pandemic; agent‐based model; discrete event simulation; system dynamics model; systematic review
Year: 2022 PMID: 36245570 PMCID: PMC9538520 DOI: 10.1002/sres.2897
Source DB: PubMed Journal: Syst Res Behav Sci ISSN: 1092-7026
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
|
Research topic: Focus on COVID‐19. Not only the paper focuses on the spread of COVID‐19, the paper related to the COVID‐19 has been taken into consideration Modelling: Simulation modelling, including agent‐based modelling (ABM) (or individual‐based model), system dynamics (SD), discrete event simulations (DES) and hybrid simulation (combine two or more of ABM, SD and DES) Study type: Paper was the original study not the any form of review paper Study language: Writing in English |
Research topic: Not related to COVID‐19. COVID‐19 is only mentioned in paper, but the actual research topic has nothing to do with COVID‐19 Modelling: Simulation modelling is not the main model used in paper Study type: The type of the paper is preprint or conference abstracts |
FIGURE 1Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow chart for systematic review of using simulation models to help contain COVID‐19. ABM, agent‐based model; DES, discrete event simulation; HS, hybrid simulation; SDM, system dynamics model
FIGURE 2Summary of simulation models, research areas and system scale applied. Note: Numbered references are listed in the supporting information. ABM, agent‐based model; DES, discrete event simulation; HS, hybrid simulation; SDM, system dynamics model [Colour figure can be viewed at wileyonlinelibrary.com]
Evaluating pharmaceutical interventions (PIs) and non‐pharmaceutical interventions (NPIs) at the national, regional and organizational levels
| Study | Mobility restrictions | Identification | Isolation and quarantine | Social distancing | Self‐prevention | Vaccination | Hospital capacity |
|---|---|---|---|---|---|---|---|
| 188 | √ | × | × | × | × | × | × |
| 85, 121, 266, 337 | × | √ | × | × | × | × | × |
| 35, 56, 167, 196, 216, 231, 236, 258, 273, 311 | × | × | √ | × | × | × | × |
| 8, 10, 22, 39, 41, 67, 74, 79, 106, 107, 111, 126, 143, 149, 156, 160, 168, 176, 195, 199, 203, 209, 219, 224, 226, 227, 232, 237, 253, 282, 291, 300, 312, 332, 352, 359, 364 | × | × | × | √ | × | × | × |
| 19 | × | × | × | × | √ | × | × |
| 6, 9, 50, 150, 198, 212, 213, 269, 275, 289, 306, 334, 336, 370 | × | × | × | × | × | √ | × |
| 20, 29 | √ | × | √ | √ | × | × | × |
| 338 | √ | × | √ | √ | √ | × | × |
| 172 | √ | × | √ | × | × | √ | × |
| 57 | √ | × | × | √ | × | × | × |
| 244 | √ | × | × | √ | √ | √ | × |
| 186 | √ | × | × | × | √ | × | × |
| 301 | √ | × | × | × | × | × | √ |
| 103, 116, 133, 158, 164, 178, 184, 207, 250, 260, 369 | × | √ | √ | × | × | × | × |
| 66, 140, 159, 169, 205, 234, 242, 251, 305 | × | √ | √ | √ | × | × | × |
| 5, 181, 318, 365 | × | √ | √ | √ | √ | × | × |
| 182 | × | √ | √ | √ | √ | √ | × |
| 36, 131, 321 | × | √ | √ | √ | × | √ | × |
| 366 | × | √ | √ | × | √ | √ | × |
| 1, 2, 12, 37, 153, 155, 238, 265, 283, 296, 310, 340, 351, 353, 355, 368 | × | × | √ | √ | × | × | × |
| 183, 225, 285, 292, 319 | × | × | √ | √ | √ | × | × |
| 61, 320 | × | × | √ | √ | √ | √ | × |
| 32 | × | × | √ | √ | × | √ | × |
| 290 | × | × | √ | × | × | × | √ |
| 51, 75, 223, 325 | × | × | × | √ | √ | × | × |
| 240 | × | × | × | √ | √ | √ | × |
| 95, 104, 361 | × | × | × | √ | × | √ | × |
| 108 | × | × | × | √ | × | × | √ |
Note: The numbered reference table is attached in the supporting information.
Categorization for examples from traditional compartmental model studies
| Key research areas | Publication |
|---|---|
|
| |
| COVID‐19 outbreak progression | Chen et al., |
| Initial epidemic features | Romo & Ojeda‐Galaviz, |
| Basic reproduction number (R0) estimation | Aggarwal & Rajpu, |
| Estimation of transmission parameters | Deng, |
| Acute‐care service demand dynamics | Dagpunar, |
| Long‐term trend prediction | Zhan, Tse, Lai, et al., |
| Investigation of the timing and size of second waves | Eguíluz et al., |
|
| |
| Mobility restrictions | Liu, He, et al., |
| Lockdown | Alrashed et al., |
| Quarantine | Barbarossa et al., |
| Contact restrictions | Liu, He,et al., |
| Social distancing | Childs et al., |
| Facemask use or face cloth covering | Gondim, |
| School closure | Gathungu et al., |
| Exit strategies | Ghamizi et al., |
|
| |
| Vaccination strategies | Buckner et al., |
| Healthcare burden | Miller et al., |
| Cost estimation of school and workplace closure | Suwantika et al., |
| Impact of relaxing existing control measures | Currie et al., |
| Risk of return to workplaces | Zhang, Ge, Liu, et al., |
| Indirect transmission mechanisms (e.g., surface‐based infection within public spaces) | Meiksin, |